Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

Table 1

Cancer stem cell markers in human.

Tumor type	Cancer stem cell markers	Reference
Lung cancer	CD133^+, CD44^+, ABCG2, ALDH, CD87^+, SP, CD90^+	[215–217]
Colon cancer	CD133^+, CD44^+, CD24^+, CD166^+, EpCAM^+, ALDH, ESA	[218, 219]
Liver cancer	CD133^+, CD44^+, CD49f^+, CD90^+, ALDH, ABCG2, CD24^+, ESA	[51, 219]
Breast cancer	CD133^+, CD44^+, CD24^−, EpCAM^+, ALDH-1	[51, 218]
Gastric cancer	CD133^+, CD44^+, CD24^+	[215, 220–222]
Leukemia (AML)	CD34^+, CD38^−, CD123^+	[216, 218, 223]
Prostate cancer	CD133^+, CD44^+, α2β1, ABCG2, ALDH	[51, 215, 223]
Pancreatic cancer	CD133^+, CD44^+, CD24^+, ABCG2, ALDH, EpCAM^+, ESA	[195, 215, 218]
Melanoma	ABCB5^+, CD20^+	[51, 217]
Head and neck cancer	SSEA-1^+, CD44^+, CD133^+	[224–226]